Volume : 10, Issue : 03, March – 2023
Title:
48.EVALUATION OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH CHRONIC KIDNEY DISEASE
Authors :
Atika Siddiqua, Ayesha Asif Ali, Salva Safdar, Syed Shoaib Hussain, Dr. Mohammed Ashfaq Hussain*
Abstract :
Background: Cardiovascular disease (CVD) is the main cause of death in the chronic kidney disease (CKD) patients, whether on dialysis or on moderate therapy. The functioning of the heart and the kidneys is tightly interlinked together. This results in the primary disorder of one of these organs causing the secondary dysfunction of another. A better understanding of cardiovascular risk factors, clinical findings and cardiac findings are main keys to develop strategies to reduce CV morbidity and mortality among CKD patients. This study discusses some aspects of CKD, CVDs, their pathophysiology and corelation of various biochemical parameters involved in both CKD and CVDs.
Objective: To evaluate the prevalence of different Cardiovascular complications occurring in Chronic Kidney Disease patients.
Materials and Methods: The study is a prospective observational study conducted in Chronic Kidney Disease patients having secondary cardiovascular complications. The enrolment was carried out between August 2021 and January 2022. Altogether 150 Indian patients diagnosed to have Chronic Kidney Disease were enrolled and are included in the study.
Results: The prevalence of heart failure (71.3%) was the highest, followed by CAD (65.3%) and ACS (48.7%). The prevalence of other CVDs such as, Valvular heart disease (n=68), Cardiomyopathy (n=65), TIA (n=42), CVA (n=30), Ventricular Arrhythmia (n=26), Atrial Fibrillation (n=24), PAD (n=14), Sudden Cardiac Arrest (n=8), were reported to be 45.3%, 43.3%, 28.0%, 20.0%, 17.3%, 16.0%, 9.3% and 5.3%, respectively. CRHD (n=6) was the least prevalent CVD (4.0%) among all the patients.
Conclusion: This study concludes that Chronic Kidney Disease is a significant risk factor for development of Cardiovascular Diseases. CV related co-morbidities in CKD have a significant role in development of CVDs in Chronic Kidney Disease patients. The incidence and prevalence of CVDs in Chronic Kidney Disease is high. The severity of Chronic Kidney Disease is associated with increased risk of cardiovascular death.
Keywords: Chronic Kidney Disease, Cardiovascular disease, Hypertension, Diabetes Mellitus, Dyslipidaemia, Cardiac Biomarkers, Heart failure, Cardio-renal syndrome, Angina, Cardiomyopathy, Arrhythmia, Atrial Fibrillation, Hypertension, End Stage Renal Disease, Haemodialysis, Serum Creatinine.
Cite This Article:
Please cite this article in press Mohammed Ashfaq Hussain et al, Evaluation Of Cardiovascular Complications In Patients With Chronic Kidney Disease., Indo Am. J. P. Sci, 2023; 10 (03).
Number of Downloads : 10
References:
1. Cardiorenal syndrome type 4: A study of cardiovascular diseases in chronic kidney disease, Indian Heart Journal, Volume 69, Issue 1, 2017, Pages 11-16, ISSN 0019-4832.
2. Andrew S. Levey, Kai-Uwe Eckardt, Yusuke Tsukamoto, Adeera Levin, Josef Coresh, Jerome Rossert, Dick D.E. Zeeuw, Thomas H. Hostetter, Norbert Lameire, Garabed Eknoyan, Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO), Kidney International, Volume 67, Issue 6,2005, Pages 2089-2100, ISSN 0085-2538.
3. José M. López-Novoa, Carlos Martínez-Salgado, Ana B. Rodríguez-Peña, Francisco J. López Hernández, Common pathophysiological mechanisms of chronic kidney disease: Therapeutic perspectives, Pharmacology & Therapeutics, Volume 128, Issue 1,2010, Pages 61-81, ISSN 0163-7258.
4. Mark J Sarnak, Cardiovascular complications in chronic kidney disease, American Journal of Kidney Diseases, Volume 41, Supplement 5 ,2003, Pages 11-17, ISSN 0272-6386.
5. Sharma M, Doley P, Das HJ. Etiological profile of chronic kidney disease: A single-center retrospective hospital-based study. Saudi J Kidney Dis Transplant 2018; 29:409-13.
6. Levey, Andrew S, and Josef Coresh. “Chronic kidney disease.” Lancet (London, England) vol. 379,9811 (2012): 165-80. doi:10.1016/S0140-6736(11)60178-5.
7. Charles A. Herzog, Richard W. Asinger, Alan K. Berger, David M. Charytan, Javier Díez, Robert G. Hart, Kai-Uwe Eckardt, Bertram L. Kasiske, Peter A. McCullough, Rod S. Passman, Stephanie S. DeLoach, Patrick H. Pun, Eberhard Ritz, Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO), Kidney International, Volume 80, Issue 6, 2011, Pages 572-586, ISSN 0085-2538, https://doi.org/10.1038/ki.2011.223.
8. Kundhal K, Lok C, E: Clinical Epidemiology of Cardiovascular Disease in Chronic Kidney Disease. Nephron Clin Pract 2005;101:c47-c52. doi: 10.1159/000086221.
9. Di Lullo L, Gorini A, Russo D, Santoboni A, Ronco C: Left Ventricular Hypertrophy in Chronic Kidney Disease Patients: From Pathophysiology to Treatment. Cardiorenal Med 2015; 5:254-266. doi: 10.1159/000435838.
10. Ardhanari, Sivakumar, Martin A. Alpert, and Kul Aggarwal. “Cardiovascular disease in chronic kidney disease: risk factors, pathogenesis, and prevention.” Adv Perit Dial 30.2 (2014): 40-53.
11. Webster AC, Nagler EV, Morton RL, Masson P. Chronic Kidney Disease. Lancet. 2017;389(10075):1238-1252. doi:10.1016/S0140-6736(16)32064-5.
12. Panagiotis Pateinakis, Aikaterini Papagianni, “Cardiorenal Syndrome Type 4—Cardiovascular Disease in Patients with Chronic Kidney Disease: Epidemiology, Pathogenesis, and Management”, International Journal of Nephrology, vol. 2011, Article ID 938651, 8 pages, 2011. https://doi.org/10.4061/2011/938651.
13. Hatamizadeh, P., Fonarow, G., Budoff, M. et al. Cardiorenal syndrome: pathophysiology and potential targets for clinical management. Nat Rev Nephrol 9, 99–111 (2013). https://doi.org/10.1038/nrneph.2012.279.
14. Junho, C.V.C., Trentin-Sonoda, M., Panico, K. et al. Cardiorenal syndrome: long road between kidney and heart. Heart Fail Rev (2022). https://doi.org/10.1007/s10741-022-10218-w.
15. Ronco C, Haapio M, House A, et al. Cardiorenal Syndrome. J Am Coll Cardiol. 2008 Nov, 52 (19) 1527–1539.
16. Sullivan, L.M., Massaro, J.M. and D’Agostino, R.B., Sr. (2004), Presentation of multivariate data for clinical use: The Framingham Study risk score functions. Statist. Med., 23: 1631-1660.